About Chemorbit Lifesciences Private Limited
Data last updated:
Chemorbit Lifesciences Private Limited is a private limited company based in Bahadurgarh, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2019PTC079652.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Bhagyasri Bondili and Pooja Nirajkumar Lakhotiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 502 Aurora Tower Omaxe North Avenue Sector 15 Opp Surya Factory, Bahadurgarh, Haryana, India – 124507.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.19 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹1.58 Lakh (net margin -0.5%) and EBITDA of ₹10.93 Lakh (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
For more details, the company can be reached via its website chemorbit.com.
Company details
Contact details
Chemorbit Lifesciences Private Limited's registered office is in Bahadurgarh, Haryana. Its website is chemorbit.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address502 Aurora Tower Omaxe North Avenue Sector 15 Opp Surya Factory, Bahadurgarh, Haryana, India – 124507
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Chemorbit Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chemorbit Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chemorbit Lifesciences Private Limited, buy the company report.
Financials of Chemorbit Lifesciences Private Limited
FY 2025 filings availableChemorbit Lifesciences Private Limited reported revenue of ₹3.19 Cr (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 8% fall in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemorbit Lifesciences Private Limited, buy the company report.
Board of directors of Chemorbit Lifesciences Private Limited
Chemorbit Lifesciences has 8 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagyasri Bondili | Director | 01 Sep 2019 | 7 Years 2 Months | Current |
| Pooja Nirajkumar Lakhotiya | Director | 01 Sep 2019 | 7 Years 2 Months | Current |
| Rakesh Kumar Also directs: Chemorbit Global Private Limited, Axylus Chemicals LLP | Director | 01 Sep 2019 | 7 Years 2 Months | Current |
| Ravinder Singh | Director | 01 Sep 2019 | 7 Years 2 Months | Current |
| Niraj Gokuldas Lakhotiya Also directs: Chemorbit Global Private Limited | Director | 09 Apr 2019 | 7 Years 6 Months | Current |
| Manohar Lal | Director | 02 Oct 2019 | 7 Years 1 Months | Current |
Peer comparison
Chemorbit Lifesciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrine Lifesciences Private Limited | ₹3.28 Cr (FY 2024) | -3.0% | Gandhinagar, Gujarat, India | |||
| Kapic Lifesciences (OPC) Private Limited | ₹3.28 Cr (FY 2025) | 140.0% | Gwalior, Madhya Pradesh, India | |||
| Chemorbit Lifesciences Private Limitedthis company | ₹3.19 Cr (FY 2024) | -₹1.58 Lakh | -0.5% | -8.0% | Bahadurgarh, Haryana, India | |
| Research Mate Lifesciences Private Limited | ₹3.15 Cr (FY 2025) | 2.0% | Delhi, India | |||
| Ekesha Lifesciences Private Limited | ₹3.14 Cr (FY 2025) | 130.0% | New Delhi, Delhi, India |
To see the full peer comparison of Chemorbit Lifesciences Private Limited, buy the company report.
Auditor
Chemorbit Lifesciences Private Limited is audited by REVANT AGARWAL & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| REVANT AGARWAL & ASSOCIATES | FY 2020 | 032809N |
Shareholding
The shareholding of Chemorbit Lifesciences Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Chemorbit Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Chemorbit Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chemorbit Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Chemorbit Lifesciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Chemorbit Lifesciences Private Limited has 8 board changes on record since 2019: 8 appointments. The latest: Manohar Lal was appointed as Director on 02 Oct 2019.
Frequently asked questions
Chemorbit Lifesciences is an active private limited company based in Bahadurgarh, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 April 2019 (7+ years old) and is registered under CIN U51909HR2019PTC079652.
Chemorbit Lifesciences has 8 current directors:
- Bhagyasri Bondili - Director
- Pooja Nirajkumar Lakhotiya - Director
- Rakesh Kumar - Director
- Ravinder Singh - Director
- Niraj Gokuldas Lakhotiya - Director
- Manohar Lal - Director
- Arun Godara - Director
- Bondili Rajesh - Director
The latest financial statements of Chemorbit Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Chemorbit Lifesciences is U51909HR2019PTC079652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemorbit Lifesciences was incorporated on 09 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Chemorbit Lifesciences by revenue are Shrine Lifesciences Private Limited, Kapic Lifesciences (OPC) Private Limited, Research Mate Lifesciences Private Limited, Ekesha Lifesciences Private Limited, all in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading).
Manohar Lal was appointed as Director on 02 Oct 2019. Bhagyasri Bondili was appointed as Director on 01 Sep 2019. Pooja Nirajkumar Lakhotiya was appointed as Director on 01 Sep 2019. Chemorbit Lifesciences has 8 board changes on record in total.
Chemorbit Lifesciences can be reached through the website chemorbit.com. Its registered office is in Bahadurgarh, Haryana, India.
The registered office of Chemorbit Lifesciences is at 502 Aurora Tower Omaxe North Avenue Sector 15 Opp Surya Factory, Bahadurgarh, Haryana, India – 124507.
Chemorbit Lifesciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Chemorbit Lifesciences is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
